Spryte Medical Receives Breakthrough Device Designation from FDA for Revolutionary neuro Optical Coherence Tomography (nOCT) Technology

BEDFORD, Mass.--(BUSINESS WIRE)--Spryte Medical, a pioneering company in advanced medical imaging technologies, proudly announces that its neuro Optical Coherence Tomography (nOCT) technology has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This recognition underscores the transformative potential of nOCT in neurointervention and cerebrovascular treatment. The FDA’s Breakthrough Device Designation is awarded to innovative technologies that offer s